✦ LIBER ✦

Protease inhibitor-based triple regimens: superior HIV therapy

Book ID: 120857387
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414230-00027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protease inhibitor-based therapy: superi

Protease inhibitor-based therapy: superior CD4+ cell counts

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Evidence supports triple therapy regimen

Evidence supports triple therapy regimens in HIV infection

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Triple-therapy regimens in HIV infection

Triple-therapy regimens in HIV infection equally effective?

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 192 KB

Efavirenz-based vs triple-nucleoside reg

Efavirenz-based vs triple-nucleoside regimens for HIV

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Recent developments in HIV protease inhi

Recent developments in HIV protease inhibitor therapy

✍ Akhteruzzaman Molla; G Richard Granneman; Eugene Sun; Dale J Kempf 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Cellular HIV-1 DNA quantitation in patie

Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens

✍ Loredana Sarmati; Saverio Giuseppe Parisi; Emanuele Nicastri; Gabriella d'Ettorr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract Simplified regimens containing protease‐inhibitors (PI)‐sparing combinations were used in patients with virological suppression after prolonged highly active antiretroviral therapy. This study evaluated the total HIV‐1 DNA quantitation as a predictor of long‐term success for PI‐sparing